On the recordJuly 21, 2014
I think the best way to do that is to ask the FDA or direct the FDA by legislation, or statute, or regulation changes, to allow that communication to go forward.
Source
congress.govEditor's note · Context
Bilirakis emphasizes the need for better communication with the FDA regarding pharmaceutical information.
Share & report
More from Gus Bilirakis
Apr 28, 2025
Mr. Speaker, in closing, I encourage a ``yes'' vote in the memory of Bill Pascrell who did such a wonderful job on this particular issue. I am glad we are getting it across the finish line. Mr. Speaker, I encourage a ``yes'' vote on this…
Apr 28, 2025
Mr. Speaker, I yield such time as she may consume to the gentlewoman from Florida (Ms. Salazar), the House sponsor of this particular bill, who is my good friend and a very effective Member of Congress.
Apr 28, 2025
Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in strong support of H.R. 973, the Setting Consumer Standards for Lithium-Ion Batteries Act, led by Representative Torres. H.R. 973 requires the Consumer…
Apr 28, 2025
Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in strong support of H.R. 2480, the Securing Semiconductor Supply Chains Act of 2025, led by Representative Landsman. This legislation directs the Department…
Other voices in this conversation
